G1 Therapeutics, Inc. (GTHX) by event type
GTHX moves most on analyst downgrades — a median of +0.21% at 30 minutes across 11 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the GTHX overview →
How GTHX reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 743 of 2,603 | 11 | +0.21% | 100% | 0.00% |
| Rating reiterations 790 of 3,522 | 32 | +0.11% | 50% | +1.32% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how GTHX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · GTHX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
| Alimera Sciences, Inc. (ALIM) | 142 | 0.00% | 42% |
| InflaRx N.V. (IFRX) | 142 | 0.00% | 48% |
| Oncocyte Corporation (OCX) | 141 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.